Gene Query: FAM169A

Dataset Description Geneva Score
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 73.77
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 73.77
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 59.09
Differentially expressed genes post knock down of lincDUSP26 52.5
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 51.54
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 47.95
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 47.95
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 33.57
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 25.91
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 23.68
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 22.97
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 22.97
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 22.67
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 20.67
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 17.37
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 16.71
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 16.37
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 15.91
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 15.89
Cerebellar differentiation in Ataxia-Telangiectasia 14.48
Lysine benzoylation is a novel histone mark [RNA-seq] 13.82
Lysine benzoylation is a novel histone mark 13.82
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 13.07
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 13.07
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 12.78
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 12.5
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 12.13
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 11.98
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 11.83
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 11.78
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 11.78
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.71
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 11.7
Gene expressions of H9s in different culture systems 11.67
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 11.48
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 11.12
p53 activity results in DNA replication fork processivity 10.76
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 10.71
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.65
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 10.25
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 10.23
WRN knockout effects upon gene expression in SW48 and OVK18 10.19
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 10.06
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 10.01
Depicting early human development and germ cell origin with porcine embryos 9.9
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.87
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 9.74
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.74
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.74
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.67
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.51
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.51
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.47
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 9.43
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.43
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 9.28
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 9.27
Evolution of a transcriptional regulator from a transmembrane nucleoporin 9.26
RNA-seq in HepG2 and IMR90 cells 9.26
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 9.25
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.22
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 9.15
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 9.11
Impact of dieldrin on transcription in Jurkat T cells 9.09
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 8.84
R430: A potent inbibitor of DNA and RNA viruses 8.84
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 8.83
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 8.79
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 8.79
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 8.69
MEIS1 regulates hematopoiesis in hPSCs 8.66
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 8.55
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.47
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.37
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 8.27
Genome-wide analysis of the Integrator complex 8.19
Genome-wide analysis of the Integrator complex (HTS) 8.19
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 8.19
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.17
Transcriptomic and gene ontology profiling of the human corneal cell types 8.15
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.08
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.06
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.87
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.83
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.83
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 7.75
Accurate annotation of human protein-coding small open reading frames 7.73
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 7.69
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 7.67
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.67
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.6
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 7.51
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.37
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.32
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.32
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.18
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.16
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 7.15
RNA-seq of YB5 cells treated with Proscillaridin A 7.1
MHC Transcriptomic landscape at haplotype-specific resolution 7.08
Ectoderm specification of H1 human embryonic stem cells 7.05
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 6.88
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.86
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 6.81
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 6.79
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 6.75
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 6.66
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.64
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.64
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.63
Generation of KRAS signatures using immortalized isogenic lung cells. 6.62
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 6.57
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.55
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.53
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 6.53
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 6.42
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 6.29
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 6.27
Dynamic reorganization of nuclear architecture during human cardiogenesis 6.27
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 6.27
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 6.25
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 6.21
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 6.18
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 6.05
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 6.04
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 6.04
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 6.04
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 6.04
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 6.01
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 6.0
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 5.87
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 5.86
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.8
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.79
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.79
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.77
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 5.76
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.75
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.75
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.75
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.73
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.72
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 5.68
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 5.68
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 5.68
LNCaP treated with iBET 5.64
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.56
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.53
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 5.51
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 5.49
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.48
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 5.47
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.46
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 5.45
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 5.44
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.42
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.42
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 5.42
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.4
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 5.36
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 5.34
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 5.34
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.28
DIGIT regulates endoderm differentiation of human embryonic stem cells 5.27
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.27
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 5.25
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 5.24
RNAseq Study in CC-671 Treated Cal-51 Cells 5.2
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.18
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 5.17
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 5.16
5.15
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.15
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 5.11
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.08
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 5.06
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 5.06
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 5.04
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.97
RNAseq in Alzheimer's Disease patients 4.91
Human cell line and subcutaneous tumor 4.9
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 4.87
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 4.81
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.81
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 4.73
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 4.73
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.73
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.72
Lineage specific differentiation is influenced by state of human pluripotency 4.67
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 4.67
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.66
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.66
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.64
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.61
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.6
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.6
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 4.58
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.57
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 4.56
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.55
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.54
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.54
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.54
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.54
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.49
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.48
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.44
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.43
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 4.39
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 4.38
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 4.37
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 4.35
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 4.34
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.33
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.33
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 4.28
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 4.28
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.26
Transcriptional profiling of LS1034 cells treated with tepoxalin 4.24
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 4.22
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 4.21
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 4.2
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.18
Differentially expressed vascular development genes for iPSC-ECs from CDI 4.15
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.12
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 4.12
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.1
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.1
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 4.1
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 4.1
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 4.1
The contribution of Alu exons to the human proteome 4.09
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.05
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.04
Gene expression analysis upon mtDNA depletion 4.04
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.99
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.98
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 3.98
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 3.98
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.98
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.98
The conserved transcriptional landscapes in human spermatogenesis 3.96
Changes in human endometrial gland transcriptome over the window of implantation 3.93
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.93
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.88
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.82
iPSC-Derived Cholangiocytes 3.81
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.81
Human HAP1 cells before and after nutrient deprivation 3.81
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.8
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.8
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 3.75
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 3.75
In vitro modeling of human germ cell development using pluripotent stem cells 3.74
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 3.73
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 3.73
Global Mapping of Human RNA-RNA Interactions 3.68
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.68
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 3.67
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.67
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.66
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.65
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.64
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.64
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.63
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.62
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.61
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.6
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.57
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.56
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 3.55
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 3.53
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.53
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.51
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.51
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 3.49
AR-independent prostate cancer is sustained through FGF signaling 3.49
Transcriptome analysis of H9 hESC derived cerebral organoids 3.41
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.37
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 3.36
RNA-seq of RKO cells with cTAZ KO or putback 3.36
Mechanistic Model-Guided Study of Embryonic Morphogenesis 3.35
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.35
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.31
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.3
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.29
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 3.28
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 3.26
Gene expression profile difference among renal location in a stone former 3.23
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 3.22
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 3.22
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.2
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 3.19
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.18
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.16
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 3.15
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.14
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 3.08
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.07
Characterization of human ILC2 subsets 3.05
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 3.0
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.98
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.97
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 2.93
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.9
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.88
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.88
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.86
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.86
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.85
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.85
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.85
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.83
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.75
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 2.73
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 2.7
Expression profiles of the four human major ectodermal lineages 2.7
Global analysis of alternative splicing regulated by RBM10 2.66
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.65
The age and genomic integrity of neurons after cortical stroke in humans 2.63
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.62
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.62
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.61
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.59
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.59
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.59
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.59
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 2.59
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.55
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.55
Gene expression signatures of innate lymphoid cells from human blood 2.53
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 2.49
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.46
DRB/GRO-Seq -/+ UV 2.42
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.42
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.4
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.4
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 2.4
BI Human Reference Epigenome Mapping Project 2.4
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.39
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.39
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.38
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 2.38
Analyses of T-ALL (COG study) 2.36
RNA sequencing of T-ALL (COG study) 2.36
Knockdown of ADNP in HCT116 colon cancer cells 2.31
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.26
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.23
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.23
FBXW7 modulates stress response by post-translational modification of HSF1 2.21
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.21
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.2
Dynamic 3D chromosomal landscapes in acute leukemia 2.2
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.18
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.18
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.18
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.17
Microglia innatly develop within cerebral organoids 2.17
hESC neural differentiation 2.16
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.16
SLIGRL-induced gene expression changes in NHEK cells 2.07
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.05
Genetic-to-epigenetic Therapy for Pancreatic Cancer 2.02
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.01
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.0
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 2.0
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.99
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 1.94
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 1.94
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.9
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.88
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.86
Gene profiling of human adult and pediatric liver cancer cells 1.85
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.8
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.74
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 1.72
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.72
FGF2 regulation of gene expression in stable inducible Neurons 1.69
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.69
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.68
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.68
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.68
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.61
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.6
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.5
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.48
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.48
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.48
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.46
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.46
Identification of long noncoding RNAs in T-ALL cell lines 1.44
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.44
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.43
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.43
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.43
Identification of expressed and conserved human non-coding RNAs 1.35
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.31
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.3
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.29
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.26
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.26
Oncogenic roles of ARID5B in T-ALL 1.25
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.25
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.24
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.21
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.21
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.19
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.19
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.18
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.18
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.16
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.08
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.07
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.07
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.07
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.07
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.07
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.06
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.06
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.04
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.02
AMPK signaling for naïve pluripotency [Hs] 0.98
AMPK signaling for naïve pluripotency 0.98
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.96
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.96
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.96
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.96
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 0.94
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.94
The MEF2B Regulatory Network 0.91
The MEF2B Regulatory Network - RNA-seq data 0.91
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.89
Ro60-knockout cells 0.88
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.87
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.87
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.85
RNA-seq of cancer cell lines treated with T-025 0.82
The circadian transcriptional landscape in primary human mammary epithelial cells 0.81
Human islets of varying quality: the good, the (not so) bad and the ugly 0.79
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 0.78
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.78
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.77
Epigenome regulation during epidermal lineage commitment 0.77
Splicing and epigenetic factors jointly regulate epidermal differentiation 0.77
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.75
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.75
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.72
Hepatocyte maturation 0.71
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.7
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.69
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.64
Loss of endometrial plasticity in recurrent pregnancy loss 0.64
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.63
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.63
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.63
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.62
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.61
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.61
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.56
Epigenomic conservation of transposable element silencing 0.55
Epigenomic conservation of transposable element silencing [RNA-seq] 0.55
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.54
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.51
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.51
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.5
IMP3 regulated gene expression in breast cancer cells 0.46
Gene expression analysis of human hepatocellular cancers 0.44
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.43
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.37
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.33
Landscape of H3K4me3 in human CD19 cells 0.32
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.32
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.29
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.29
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.28
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.28
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.27
Identification of long noncoding RNAs regulated by p53 0.27
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.25
Ribosomal protein RPL26 is the principal target of UFMylation 0.24
High-resolution comparative analysis of great ape genomes 0.24
Effect of nuclear IL-33 on gene expression 0.2
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.18
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.18
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.17
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.16
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.15
Leucegene: ALL sequencing 0.1
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.07
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.05
Multiple sclerosis and EAE 0.05
Human optic chiasm from healthy controls and multiple sclerosis patients 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation